Increased frequency of CCR4+ and CCR6+ memory T-cells including CCR7+CD45RAmed very early memory cells in granulomatosis with polyangiitis (Wegener's)

ar37941478-6354 Research article Increased frequency of CCR4+ and CCR6+ memory T-cells including CCR7+CD45RAmed very early memory cells in granulomatosis with polyangiitis (Wegener's) FaginUrsulaursula.fagin@uk-sh.de PitannSilkesilke.pitann@arcor.de GrossLWolfgangw.gross@klinikumbb.de LamprechtPeterpeter.lamprecht@uk-sh.de

Department of Rheumatology, Vasculitis Center UKSH and Clinical Center Bad Bramstedt, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany

Arthritis Research & Therapy 1478-6354 2012 14 2 R73 http://arthritis-research.com/content/14/2/R73 10.1186/ar379422490506 2511201113201210420121042012 2012Fagin et al.; licensee BioMed Central Ltd.This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Introduction

Chemokine receptors play an important role in mediating the recruitment of T cells to inflammatory sites. Previously, small proportions of circulating Th1-type CCR5+ and Th2-type CCR3+ cells have been shown in granulomatosis with polyangiitis (GPA). Wondering to what extent CCR4 and CCR6 expression could also be implicated in T cell recruitment to inflamed sites in GPA, we investigated the expression of CCR4 and CCR6 on T cells and its association with T cell diversity and polarization.

Methods

Multicolor flow cytometry was used to analyze CCR4, CCR6, and intracellular cytokine expression of T cells from whole blood of GPA-patients (n = 26) and healthy controls (n = 20). CCR7 and CD45RA were included for phenotypic characterization.

Results

We found a significant increase in the percentages of circulating CCR4+ and CCR6+ cells within the total CD4+ T cell population in GPA. In contrast, there was no difference in the percentages of CD8+CCR4+ and CD8+CCR6+ T cells between GPA and healthy controls. CCR4 and CCR6 expression was largely confined to central (T_CM) and effector memory T cells (T_EM, T_EMRA). A significant increase in the frequency of CCR4+ and CCR6+ T_EMRAand CCR6+ T_CMwas shown in GPA. Of note, we could dissect CCR4 and CCR6 expressing CCR7+CD45RA^medvery early memory T cells (T_VEM) from genuine CCR7+CD45RA^highnaïve T cells lacking CCR4 and CCR6 expression for peripheral tissue-migration within the CCR7+CD45RA+ compartment. The frequencies of CCR4+ and CCR6+ T_VEMwere also significantly increased in GPA. An increased percentage of IL-17+ and IL-22+ cells was detected in the CCR6+ cell subsets and IL-4+ cells in the CRR4+ cell subset when compared with CD4+ cells lacking CCR4 and CCR6 expression.

Conclusions

Increased frequencies of circulating CCR4+ and CCR6+ memory T cell subsets including hitherto unreported T_VEMsuggest persistent T cell activation with the accumulation of CCR4+ and CCR6+ cells in GPA. CCR4 and CCR6 could be involved in the recruitment of T cells including cytokine-producing subsets to inflamed sites in GPA.

Introduction

T cells display considerable heterogeneity in terms of phenotype, function, and anatomical distribution. Whereas naïve T cells represent a relatively homogenous population, primed T cells acquire effector functions and differentiate into distinct effector and memory subsets. Whereas naïve and central memory T cells home to secondary lymphoid organs to mount antigen-driven proliferative responses, effector memory T cells migrate into peripheral tissues to display immediate effector functions such as cytokine production or cytotoxicity or both 1 2 . The process of T cell recruitment from blood into tissue is controlled by adhesion molecules, in which chemokine receptors have an important role 2 .

Previously, we showed that a small proportion of circulating memory T cells displays T-helper cell 1 (Th1)-type CC chemokine receptor (CCR) 5 and Th2-type CCR3 expression in granulomatosis with polyangiitis (GPA) 3 . GPA is a rare chronic inflammatory disorder of unknown etiology and is characterized by necrotizing granulomatosis of the upper or lower respiratory tract or both and a systemic autoimmune vasculitis preferentially affecting pulmonary and renal small vessels. The vasculitis is associated with highly specific anti-neutrophil cytoplasmic autoantibodies to proteinase 3 (PR3-ANCA) 4 . T cells are abundant in inflammatory lesions in GPA. CCR5, CCR3, and their chemokine ligand CCL5 (regulated upon activation in normal T cells, expressed and secreted, or RANTES) are expressed in granulomatous lesions of the respiratory tract. These studies suggested that CCR5 and CCR3 could be involved in the recruitment of interferon-gamma (IFNγ)-producing and tumor necrosis factor-alpha-producing Th1- and interleukin (IL)-4-producing Th2-type cells to inflammatory sites in GPA 5 6 7 . More recently, IL-17-producing PR3-specific Th17 cells have been implicated in the maintenance of chronic inflammation and autoimmunity in GPA 8 9 10 . CCR4⁺T cells have been reported to secrete IL-4, whereas CCR6⁺cells produce IL-17 11 12 . To investigate the extent to which the chemokine receptors CCR4 and CCR6 could be implicated in T-cell recruitment in GPA, we analyzed CCR4 and CCR6 expression on circulating T cells, assigned CCR4- and CCR6-expressing cells to the respective memory cell subsets, and determined the cytokine production of CCR4⁺and CCR6⁺T cells.

Materials and methods

Study population

Patients fulfilled the American College of Rheumatology criteria and the Chapel Hill Consensus Conference definition for GPA, respectively 13 14 . Disease activity was recorded in accordance with European League Against Rheumatism recommendations (Table 1) 15 . All patients and controls provided informed consent. The study was approved by the local ethics committee (#07-059).

Table 1

Clinical and laboratory characteristics of patients with GPA and healthy controls

Patients with GPA in remission

Patients with active GPA

Healthy controls

Number

Age in years, mean (range)

58 (38-83)

55 (27-77)

51 (21-78)

Sex, male/female

10/2

10/4

11/9

BVAS V3.0, mean (range)

10 (4-21)

CRP in mg/L, mean (range)

8 (1-17)

33 (1-86)

PR3-ANCA, positive/negative

9/3

14/0

Methotrexate, number

Azathioprine, number

Leflunomide, number

Cyclophosphamide, number

Prednisolone, number

Prednisolone dosage in mg

6.1 ± 0.8

11.9 ± 1.9^a

No treatment

Remission was defined as BVAS V3.0 (Birmingham Vasculitis Activity Index version 3.0) of 0. Disease activity in patients either with first manifestation or relapsing was defined as BVAS V3.0 of at least 1 (15). Prednisolone dosage is expressed as mean ± standard error of the mean. ^aP < 0.05 by Mann-Whitney U test. CRP, C-reactive protein; GPA, granulomatosis with polyangiitis; PR3-ANCA, anti-neutrophil cytoplasmic autoantibodies targeting proteinase 3.

Antibodies used for flow cytometry

The following antibodies were used in different combinations: Pacific blue (PB)-conjugated anti-CD3, PB- or phycoerythrin (PE)-conjugated anti-CD4, peridinin chlorophyll protein (PerCP)- or allophycocyanine-cyanine dye 7 (APC-Cy7)-conjugated anti-CD8, fluorescein isothiocyanate (FITC)-conjugated anti-CD45RA, Alexa Fluor 647-conjugated anti-CCR7, PE-Cy7- and PE-conjugated anti-CCR4, PE-conjugated anti-CCR6, APC-Cy7-conjugated anti-IFNγ, PE-Cy7-conjugated anti-IL-4, and Alexa Fluor 488-conjugated anti-IL-17a from eBioscience (Frankfurt, Germany) and APC-conjugated anti-IL-22 from R&D Systems (Wiesbaden, Germany). Appropriate isotype controls were included in the experimental setup. All antibodies (unless indicated otherwise) were purchased from BD Biosciences (Heidelberg, Germany).

Surface marker and intracellular cytokine staining

Flow cytometry was performed to characterize T cell populations at the single-cell level. Staining of cellular surface markers was performed by using freshly collected whole blood (Li-heparin) as described earlier 3 . Briefly, previously determined optimal concentrations of fluorochrome-conjugated monoclonal antibodies for cell surface antigens were added to 100 μL of whole blood and incubated 45 minutes in the dark at 4°C. Subsequently, erythrocytes were lysed by the addition of FACS (fluorescence-activated cell sorting) Lysing Solution (BD Pharmingen, Heidelberg, Germany). After incubation for another 10 minutes in the dark at room temperature, cells were washed twice with phosphate-buffered saline/0.01% bovine serum albumin and immediately analyzed by FACS.

For intracellular cytokine staining, freshly collected whole blood was stimulated with phorbol myristate acetate (Sigma, Munich, Germany) (10 ng/mL) and ionomycin (Sigma) (1 μg/mL) for 4 hours at 37°C in a humidified atmosphere with 5% CO₂. Brefeldin (Sigma) (10 μg/mL) was added at the beginning of the stimulation to inhibit cytokine secretion. After staining for surface antigens and lysing of erythrocytes with FACS Lysing Solution, cells were fixed and permeabilized with Cytofix/Cytoperm in accordance with the instructions of the manufacturer (BD Pharmingen). Staining of intracytoplasmatic cytokines was performed at 4°C for 45 minutes in the dark with previously determined optimal concentrations of fluorochrome-conjugated monoclonal antibodies for cytokines or appropriate negative (isotype) controls. Besides appropriate isotype controls, an unstimulated sample was included for each patient and control as a negative control.

Flow cytometric analysis

Multicolor flow cytometric analysis was performed on a FACS Canto II cytometer by using FACSDiva software (BD Biosciences). Lymphocytes were gated for analysis on the basis of light scattering properties and of CD3, CD4, and CD8 staining. Positively and negatively stained populations were calculated by quadrant dot plot analysis determined by isotype controls.

Statistical analysis

Statistics were performed by using Prism 4.0 (GraphPad Software, La Jolla, CA, USA). Comparisons between patients and control subjects were done by employing the non-parametric Mann-Whitney U test. P values equal to or less than 0.05 were considered to be statistically significant.

Results

Increased frequency of CCR4- and CCR6-expressing CD4⁺T cells in granulomatosis with polyangiitis

To assess CCRs relevant for migration to peripheral tissues, we determined the expression of the CCR4 and CCR6 on peripheral blood T cells in patients with GPA and healthy controls. We found a significant increase in the percentages of CCR4- and CCR6-expressing cells within the total CD4⁺T cell population in patients with GPA compared with healthy individuals (Figure 1a, b). Apart from the CCR4⁺CCR6^-and CCR4^-CCR6⁺'single positive' subsets, a smaller fraction of CCR4⁺CCR6⁺'double positive' cells was detected within the CD4⁺T cell population in patients with GPA and healthy controls (17.5% ± 4.8% versus 10.3% ± 0.6%, mean ± standard error of the mean, no significant difference, Mann-Whitney U test). Conversely, the remainder of cells within the CD4⁺T-cell population were CCR4^-CCR6^-'double negative' cells. In contrast, there was no difference in the percentages of CD8⁺CCR4⁺and CD8⁺CCR6⁺T cells between patients with GPA and healthy controls (data not shown).

Figure 1

Increased frequencies of CD4⁺CCR4⁺and CD4⁺CCR6⁺T cells in patients with granulomatosis with polyangiitis (GPA)

Increased frequencies of CD4⁺CCR4⁺and CD4⁺CCR6⁺T cells in patients with granulomatosis with polyangiitis (GPA). Percentages of CCR4⁺(a) and CCR6⁺(b) cells within the total CD4⁺T cell population in patients with GPA and healthy controls (HCs). Percentages of positive cells were assessed by flow cytometry. Values are presented as mean ± standard error of the mean. ***P < 0.001, Mann-Whitney U test. CCR, CC chemokine receptor.

CCR4 and CCR6 are expressed on distinct memory cell populations, including CCR7⁺CD45RA^medvery early memory cells

Having shown a significant increase in the frequencies of CCR4- and CCR6-expressing CD4⁺T cells in patients with GPA, we were interested in phenotypic features of CCR4- and CCR6-expressing CD4⁺T cells next. To assign CCR4⁺and CCR6⁺cells to the respective naïve and memory cell subsets, cells were additionally stained with fluorescent-conjugated antibodies for CD45RA and CCR7 to allow discrimination into diverse T cell subsets 2 16 17 18 . By the use of these markers, we found that CCR4 and CCR6 expression was confined largely to the circulating CCR7⁺CD45RA^-central memory (T_CM) and CCR7^-CD45RA^-(T_EM) and CCR7^-CD45RA⁺(T_EMRA) effector memory cell subsets within the total CD4⁺T cell population. A significant increase in the frequency of CCR4⁺and CCR6⁺cells was remarkable in the CCR7^-CD45RA⁺effector memory (T_EMRA) subset in patients with GPA. A significant increase in CCR6⁺cells was also found in the CCR7⁺CD45RA^-central memory T-cell subset (T_CM). However, significantly increased percentages of CCR4⁺and CCR6⁺cells were also detected in the CCR7⁺CD45RA⁺population, which contains naïve T cells (T_N) by definition (Figure 2a, b). Dissecting the CCR7⁺CD45RA⁺population with respect to CD45RA fluorescence intensity, we detected two subsets in the CCR7⁺CD45RA⁺population. CCR7⁺CD45RA^highT cells generally lacked CCR4 and CCR6 expression with the exception of three patients with GPA. In contrast, CCR7⁺CD45RA^medT cells displayed CCR4 and CCR6 expression. We found higher frequencies of CCR4⁺and CCR6⁺cells within the CCR7⁺CD45RA^medT cell subset in patients with GPA compared with healthy controls (Figure 2c, d). Thus, the CCR7⁺CD45RA⁺population contained genuine CCR7⁺CD45RA^highT_Nlacking CCR4 and CCR6 expression and another CCR7⁺CD45RA^medT cell subset comprising CCR4⁺and CCR6⁺cells. The latter was reminiscent of so-called very early memory T cells (T_VEM) 19 .

Figure 2

Increased percentages of CCR4⁺and CCR6⁺memory T cell subsets in patients with granulomatosis with polyangiitis (GPA)

Increased percentages of CCR4⁺and CCR6⁺memory T cell subsets in patients with granulomatosis with polyangiitis (GPA). Percentages of CD4⁺CCR4⁺(a) and CD4⁺CCR6⁺(b) T cells in the CCR7⁺CD45RA^-central memory (T_CM), CCR7^-CD45RA^-effector memory (T_EM), CCR7⁺CD45RA⁺'naïve by definition' (T_N), and CCR7^-CD45RA⁺'revertant' effector memory (T_EMRA) populations. (c) Dissection of the CD4⁺CCR7⁺CD45RA⁺population with regard to CD45RA fluorescence intensity into CCR7⁺CD45RA^highcells representing genuine T_Nand CCR7⁺CD45RA^medcells reminiscent of very early memory T cells (T_VEM). Percentages of CCR4⁺and CCR6⁺cells in the CCR7⁺CD45RA^medand CCR7⁺CD45RA^highsubsets are shown. (d) Representative quadrant dot-plot analysis showing segregation of the gated CD4⁺CCR7⁺CD45RA⁺T cell population into two subsets. CCR7⁺CD45RA^medT cells displayed CCR4 and CCR6 expression (T_VEM). CCR7⁺CD45RA^highT cells lacked CCR4 and CCR6 expression (genuine T_N). Numbers in quadrants and histograms represent percentages of cells. Percentages of positive cells were assessed by flow cytometry. Values are presented as mean ± standard error of the mean. *P < 0.05, ***P < 0.001, Mann-Whitney U test. CCR, CC chemokine receptor; HC, healthy control.

Decreased frequency of CCR7⁺CD45RA^highnaïve T cells and unreduced frequency of CCR7⁺CD45RA^medvery early memory T cells in granulomatosis with polyangiitis

Earlier studies have reported significantly lower percentages of peripheral blood T_Nby using CCR7 and CD45RO or CD45RB expression for the phenotypic characterization of T cells in patients with GPA 20 21 . In this study, we showed a segregation of the CCR7⁺CD45RA⁺T cell compartment into different two subsets based on CCR4 and CCR6 expression and CD45RA fluorescence intensity. This prompted us to investigate whether T_Nand T_VEMfrequencies were likewise decreased within the total CD4⁺T-cell population. In line with the aforementioned earlier studies, we found a significantly lower percentage of CCR7⁺CD45RA^highT_Nin patients with GPA compared with healthy controls 20 21 . In contrast, CCR7⁺CD45RA^medT_VEMfrequencies were similar in patients with GPA and healthy individuals (Figure 3).

Figure 3

Decreased frequency of naïve T cells (T_N) and unreduced frequency of very early memory T cells (T_VEM) in patients with granulomatosis with polyangiitis (GPA)

Decreased frequency of naïve T cells (T_N) and unreduced frequency of very early memory T cells (T_VEM) in patients with granulomatosis with polyangiitis (GPA). Percentages of CCR7⁺CD45RA^medT_VEMand CCR7⁺CD45RA^highT_Nin the CD4⁺T cell population are shown. Percentages of positive cells were assessed by flow cytometry. Values are presented as mean ± standard error of the mean. **P < 0.01, Mann-Whitney U test. CCR, CC chemokine receptor; HC, healthy control.

Distinct cytokine-producing subsets within CCR4⁺and CCR6⁺T-cell populations

We showed increased frequencies of circulating CCR4- or CCR6-expressing (or both) CD4⁺T_CM, T_EMRA, and T_VEMin patients with GPA. To investigate functional features of CCR4⁺and CCR6⁺cells within the total CD4⁺T cell population, peripheral blood cells were stained for intracellular cytokines. An IFNγ⁺cell fraction was found in all CCR4⁺or CCR6⁺subsets or both. An increased percentage of IL-17⁺and IL-22⁺cells was detected in the CCR4^-CCR6⁺'single positive' and CCR4⁺CCR6⁺'double positive' cell fractions when compared with the CCR4^-CCR6^-'double negative' cell subset. Furthermore, an increased frequency of IL-4⁺cells was shown in the CCR4⁺CCR6^-'single positive' cell fraction compared with the CCR4^-CCR6^-'double negative' cell subset in both patients with GPA and healthy controls. CCR4^-CCR6⁺'single positive' and CCR4⁺CCR6⁺'double positive' cells differed from each other with respect to the percentage of IFNγ-producing cells, which was significantly higher in the CCR4-CCR6⁺'single positive' fraction (P < 0.01, Mann-Whitney U test). The CCR4^-CCR6^-'double negative' cell subset differed from the other subsets in that only an IFNγ⁺cell fraction was remarkable in this subset (Table 2). Less than 1% of cells displayed intracellular co-expression of IL-17 and IL-22 in CCR6⁺cells within the total CD4⁺T-cell population (data not shown). Thus, circulating CD4⁺CCR4⁺and CD4⁺CCR6⁺T cell populations comprised distinct subsets of cytokine-producing cells.

Table 2

Percentages of cytokine-producing CCR4⁺and/or CCR6⁺cell subsets within the total CD4⁺T cell population compared with the CCR4^-CCR6^-cell subset

Granulomatosis with polyangiitis

CCR4^-CCR6^-cells

CCR4⁺CCR6^-cells

CCR4^-CCR6⁺cells

CCR4⁺CCR6⁺cells

Percentage of IFNγ⁺cells

11.3 ± 5.1

5.5 ± 2.0

28.2 ± 4.3

4.0 ± 0.5

Percentage of IL-4⁺cells

1.0 ± 0.5

5.5 ± 1.5^a

0.6 ± 0.3

1.0 ± 0.4

Percentage of IL-17⁺cells

0.1 ± 0.0

7.8 ± 1.8^a

9.5 ± 0.9^b

Percentage of IL-22⁺cells

0.1 ± 0.0

0.2 ± 0.1

2.4 ± 0.5^a

3.4 ± 0.6^a

Healthy controls

CCR4^-CCR6^-cells

CCR4⁺CCR6^-cells

CCR4^-CCR6⁺cells

CCR4⁺CCR6⁺cells

Percentage of IFNγ⁺cells

21.7 ± 8.4

13.1 ± 2.0

30.7 ± 1.1

6.0 ± 0.5

Percentage of IL-4⁺cells

1.0 ± 0.3

5.4 ± 1.0^a

1.5 ± 0.4

2.2 ± 0.6

Percentage of IL-17⁺cells

0.1 ± 0.0

0.2 ± 0.0

9.1 ± 1.0^a

9.7 ± 1.8^a

Percentage of IL-22⁺cells

0.1 ± 0.0

0.4 ± 0.2

3.3 ± 0.9^a

5.0 ± 2.1^a

Percentages of positive cells were assessed by flow cytometry. Values are expressed as mean ± standard error of the mean. ^aP < 0.5, ^bP < 0.01, Mann-Whitney U test. CCR, CC chemokine receptor; IFNγ, interferon-gamma; IL, interleukin.

Discussion

Chemokine receptors play an important role in mediating T cell recruitment to distinct anatomical sites and tissues 2 . Whereas the CC chemokine receptor CCR7 mediates homing of naïve (T_N) and central memory (T_CM) T cells to lymph nodes, other CC and CXC chemokine receptors (CCR/CXCR) trigger intravascular adhesion and direct migration of effector memory T cell subsets (CD45RA^-T_EMand CD45RA⁺'reverted' T_EMRA) into peripheral tissues for patrol and recruitment to inflammatory sites 2 19 . Previously, cloned CCR6⁺cells from peripheral blood and inflammatory sites in Crohn's disease have been shown to produce IL-17. In contrast, CCR4⁺cells secrete IL-4 11 12 22 . Recently, Th17-, Th22-, and Th2-type PR3-specific cells have been suggested to be involved in chronic inflammation and autoimmunity in GPA 8 9 10 23 . Moreover, an increased proportion of circulating CD45RC^lowTh2-type and Th17 cells has been reported in ANCA-associated vasculitides, including GPA. The increase is independent of disease duration and treatment 24 . Therefore, to investigate the extent to which CCR4 and CCR6 expression could be implicated in T-cell recruitment in GPA, we analyzed the expression of these chemokine receptors on T cells.

In this study, we found increased frequencies of circulating CCR4⁺and CCR6⁺cells within the total CD4⁺T cell population in GPA. In contrast, we found no significant increase in the frequencies of CCR4⁺and CCR6⁺cells in the total CD8⁺T cell population. CCR4 and CCR6 expression suggests T cell activation 11 12 . Persistent T cell activation regardless of clinical disease activity has been reported in GPA 20 21 25 . Recently, stable CCR6 expression was reported to be controlled by epigenetic mechanisms 26 . In line with previous reports, CCR4 and CCR6 expression was confined largely to circulating CCR7⁺CD45RA^-central memory (T_CM), CCR7^-CD45RA^-(T_EM), and CCR7^-CD45RA⁺(T_EMRA) effector memory CD4⁺T cells 11 12 . We found a significant increase in the frequency of CCR4⁺and CCR6⁺T_EMRAand CCR6⁺T_CMin patients with GPA. Surprisingly, CCR4⁺and CCR6⁺cells were also detected within the CCR7⁺CD45RA⁺population, which contains the naïve T cell subset (T_N) by definition. T_Nare CD45RA⁺and express CCR7 for peripheral lymph node homing but lack receptors such as CCR4 and CCR6 for the migration to peripheral tissues 2 16 17 18 . Further analysis dissecting the CCR7⁺CD45RA⁺population with regard to CD45RA fluorescence intensity disclosed that the CCR7⁺CD45RA⁺T-cell compartment contained two subsets. One subset of CCR7⁺CD45RA^highT cells generally lacked CCR4 and CCR6 expression with the exception of three patients with GPA. Thus, CCR7⁺CD45RA^highT cells represented genuine T_N. CCR4 and CCR6 expression on CCR7⁺CD45RA^highT_Nin individual patients with GPA could represent T_Nactivation, which has been reported before by demonstrating an increased frequency of CD4⁺CD45RO^-FoxP3^-T_Nexpressing the activation marker CD25 20 25 . In line with earlier studies, we showed that the percentage of CCR7⁺CD45RA^highT_Nwithin the total CD4⁺T cell population was significantly lower in patients with GPA 20 21 . In contrast, the percentage of CCR7⁺CD45RA^medT cells was not decreased in patients with GPA. CCR7⁺CD45RA^medT cells displayed CCR4 and CCR6 expression reminiscent of so-called very early memory T cells (T_VEM). Higher frequencies of CCR4⁺and CCR6⁺cells within the CCR7⁺CD45RA^medT_VEMsubset were found in patients with GPA compared with healthy controls. T_VEMhave been described earlier as 'apparently T_N' oddly displaying chemokine receptors for both lymph node homing (CCR7) and peripheral tissue migration (CCR4 and CXCR3) in healthy individuals by Song and colleagues 19 . Analysis of the proliferation history, T-cell receptor repertoire, and cytokine response of CCR4- and CXCR3-expressing CCR7⁺CD45RO^-T cells suggests that these cells represent T_VEM, which have proceeded only a short way along the differentiation pathway from T_Nto T_CMor T_EM. T_VEMare still multifunctional but finally differentiate into either T_CMor T_EM 19 .

Earlier studies showed that chemokine receptor expression for lymph node homing (CCR7) and peripheral tissue migration (for example, CCR4) is not mutually exclusive on T cell subsets 27 . The migratory behavior of T_EMdisplaying dual-chemokine receptor expression is determined by chemotactic gradients and cytokine- and T-cell receptor (TCR)-mediated signals 28 . CCR4-expressing CCR7⁺T_EMhave been reported in inflamed peripheral tissues (for example, in psoriasis and juvenile idiopathic arthritis) 29 30 . Whereas CCR7^-T_EMremain in the peripheral tissue, CCR7⁺T_EMmigrate to peripheral tissues and subsequently exit the tissue to enter draining lymph nodes in different animal models 31 32 . Although CCR7⁺T_EMretain a capability to enter lymph nodes, inflammatory cytokines can subvert migration of CCR7⁺T_EM, resulting in the retention of CCR7⁺T_EMin the inflamed synovial tissue 33 . Cytokines also drive the differentiation of CCR4-expressing CCR7⁺T_CMto CCR7^-T_EM 22 . Of note, CCR7⁺T_EMaccumulate in areas of ectopic lymphoid tissue in the inflamed synovial tissue 30 . In contrast, CCR4-expressing CCR7⁺T_VEMreside or recirculate in secondary lymphoid tissues, where they continue to differentiate and acquire further chemokine receptors for peripheral tissue migration 19 .

Having shown increased frequencies of circulating CCR4- and CCR6-expressing CD4⁺memory T cell subsets, including T_VEMin patients with GPA, we analyzed the cytokine production of CCR4⁺and CCR6⁺T cells. Previously, cloned and, as such, preselected CCR6⁺cells were reported to secrete IL-17, whereas CCR4⁺T cells produce IL-4 11 12 . In our study, we found an increased percentage of IL-17- and IL-22-producing cells in the CCR4^-CCR6⁺'single positive' and CCR4⁺CCR6⁺'double positive' cell subsets and an increased frequency of IL-4⁺cells in the CRR4⁺CCR6^-'single positive' cell subset compared with the CCR4^-CCR6^-'double negative' cell subset within the total circulating CD4⁺T-cell population. Thus, in line with earlier studies, we found Th17 cells within circulating CCR6⁺cells and Th2-type cells among CCR4⁺cells 11 12 . Moreover, CCR4^-CCR6⁺'single positive' and CCR4⁺CCR6⁺'double positive' cells differed from each other with respect to the percentage of IFNγ-producing cells, which was higher in the former cell population.

Conclusions

We found increased frequencies of circulating CCR4⁺and CCR6⁺T cells in patients with GPA. CCR4 and CCR6 expression was confined largely to central memory (T_CM) and effector memory (T_EMand T_EMRA) subsets but could also be detected on very early memory T cells (T_VEM) displaying chemokine receptors for both lymph node homing (CCR7) and peripheral tissue migration (CCR4 and CCR6). CD4⁺CCR4⁺and CD4⁺CCR6⁺T-cell populations contained distinct cytokine-producing subsets. Our data suggest that CCR4 and CCR6 could be involved in the recruitment of different T cell subsets, including cytokine-producing cells, to inflamed sites in patients with GPA. Further studies are needed to assess CCR4⁺and CCR6⁺T cell reactivity to the respective chemokine gradients and the expression of CCR4, CCR6, and their chemokine ligands in inflammatory lesions in patients with GPA in order to define new targets for therapeutic intervention.

Abbreviations

ANCA: anti-neutrophil cytoplasmic autoantibodies; APC: allophycocyanine; APC-Cy7: allophycocyanine-cyanine dye 7; CCR: CC chemokine receptor; CXCR: CXC chemokine receptor; Cy7: cyanine dye 7; FACS: fluorescence-activated cell sorting; GPA: granulomatosis with polyangiitis (Wegener's); IFNγ: interferon-gamma; IL: interleukin; PB: Pacific blue; PE: phycoerythrin; PR3: proteinase 3; T_CM: central memory T cells; T_EM: CD45RA^-effector memory T cells; T_EMRA: CD45RA⁺effector memory T cells; Th: T-helper cell; T_N: naïve T cells; T_VEM: very early memory T cells.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

UF participated in the design of the study, acquisition of data, interpretation of the results, and drafting of the manuscript. SP participated in the acquisition of data, interpretation of results, and drafting of the manuscript. WLG participated in the coordination of the study and assisted in the interpretation of the results. PL conceived the study, participated in its design and coordination and the interpretation of the results, and drafted of the manuscript. All authors read and approved the final manuscript.

Authors' information

UF, Ph.D., is a biologist. SP is a medical technician. WLG, M.D., is the director of the Department of Rheumatology and spokesman of the Vasculitis Center UKSH and Clinical Research Unit 170. PL, M.D., is the coordinator of Clinical Research Unit 170. All authors are at the Department of Rheumatology, Vasculitis Center UKSH and Clinical Center Bad Bramstedt, University of Lübeck (Lübeck, Germany).

Acknowledgements

This work was supported by the German Research Foundation-funded Clinical Research Unit 170 'Early pathogenesis of Wegener's granulomatosis', Excellence Cluster 'Inflammation at Interfaces' (JRG-Ih), University-funded Priority Program Autoimmunity, and a grant from the Association for the Promotion of the Study and Control of Rheumatic Diseases (Bad Bramstedt, Germany).

Heterogeneity of CD4+ and CD8+ T cellsWoodlandDLDuttonRWCurr Opin Immunol20031533634210.1016/S0952-7915(03)00037-212787761T-cell function and migration. Two sides of the same coinVon AndrianUMackayCRN Engl J Med20003431020103410.1056/NEJM20001005343140711018170Heterogeneity of CD4+ and CD8+ memory T cells in localized and generalized Wegener's granulomatosisLamprechtPErdmannAMuellerACsernokEReinhold-KellerEHoll-UlrichKFellerACBruehlHGrossWLArthritis Res Ther20035R253110.1186/ar61015443012716450Update on clinical, pathophysiological and therapeutic aspects in ANCA-associated vasculitidesLamprechtPHolleJGrossWLCurr Drug Discov Technol2009624125110.2174/15701630978986899420025591Expression of the chemokine RANTES in pulmonary Wegener's granulomatosisCoulomb-L'HermineACapronFZouWPiardFGalateauFLaurentPCrevonMCGalanaudPEmilieDHum Pathol20013232032610.1053/hupa.2001.2275711274642Differences in CCR5 expression on peripheral blood CD4+CD28- T-cells and granulomatous lesions between localized and generalized Wegener's granulomatosisLamprechtPBruhlHErdmannAHoll-UlrichKCsernokESeitzerUMackMFellerACReinhold-KellerEGrossWLMullerAClin Immunol20031081710.1016/S1521-6616(03)00121-912865065Th2 dominance in nasal mucosa in patients with Wegener's granulomatosisBaldingCEHowieAJDrake-LeeABSavageCOClin Exp Immunol200112533233910.1046/j.1365-2249.2001.125002332.x190613011529927Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remissionAbdulahadWHStegemanCALimburgPCKallenbergCGArthritis Rheum2008582196220510.1002/art.2355718576340Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitisNogueiraEHamourSSawantDHendersonSMansfieldNChaveleKMPuseyCDSalamaADNephrol Dial Transplant2010252209221710.1093/ndt/gfp78320100727Distinct proteinase 3-induced cytokine pattern's in Wegener's granulomatosis, Churg-Strauss syndrome, and healthy controlsFaginUCsernokEMüllerAPitannSFazioJKrauseKBremerPWipfler-FreißmuthEMoosigFGrossWLLamprechtPClin Exp Rheumatol201129Suppl 64S57S6221470489Phenotypic and functional features of human Th17 cellsAnnunziatoFCosmiLSantarlasciVMaggiLLiottaFMazzinghiBParenteEFilìLFerriSFrosaliFGiudiciFRomagnaniPParronchiPTonelliFMaggiERomagnaniSJ Exp Med20072041849186110.1084/jem.20070663211865717635957Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cellsAcosta-RodriguezEVRivinoLGeginatJJarrossayDGattornoMLanzavecchiaASallustoFNapolitaniGNat Immunol2007863964617486092The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosisLeavittRYFauciASBlochDAMichelBAHunderGGArendWPCalabreseLHFriesJFLieJTLightfootRWJrMasiATMcShaneDJMillsJAStevensMBWallaceSLZvaiflerNJArthritis Rheum199033110111072202308Nomenclature of systemic vasculitides. Proposal of an international consensus conferenceJennetteJCFalkRJAndrassyKBaconPAChurgJGrossWLHagenECHoffmanGSHunderGGKallenbergCGMcCluskeyRTSinicoRAReesAJvan EsLAWaldherrRWiikAArthritis Rheum19943718719210.1002/art.17803702068129773EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitisHellmichBFlossmannOGrossWLBaconPCohen-TervaertJWGuillevinLJayneDMahrAMerkelPARaspeHScottDGIWitterJYaziciHLuqmaniRthe European Vasculitis Study GroupAnn Rheum Dis20076660561710.1136/ard.2006.062711270377517170053Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsSallustoFLenigDFörsterRLippMLanzavecchiaANature199940170871210.1038/4438510537110Phenotype and Function of Human T Lymphocyte Subsets: Consensus and IssuesAppayVvan LierRAWSallustoFRoedererMCytometry A2008739759831878526711-color, 13-parameter flow cytometry: identification of human naïve T cells by phenotype, function, and T-cell receptor diversityDe Rosa HerzenbergLAHerzenbergLARoedererMNat Med2001724524810.1038/8470111175858Characterization of subsets of CD4+ memory T cells reveals early branched pathways of T cell differentiation in humansSongKRabinRLHillBJDe RosaSCPerfettoSPZhangHHFoleyJFReinerJSLiuJMattapallilJJDouekDCRoedererMFarberJMProc Natl Acad Sci USA20051027916792110.1073/pnas.0409720102113181615905333Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitisMarinakiSNeumannIKälschAIGrimmingerPBreedijkABirkRSchmittWWaldherrRYardBAvan der WoudeFJClin Exp Immunol200514018119110.1111/j.1365-2249.2005.02731.x180933615762890Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosisAbdulahadWHvan der GeldYMStegemanCAKallenbergCGKidney Int20067093894710.1038/sj.ki.500167016837919Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cellsRivinoLMessiMJarrossayDLanzavecchiaASallustoFGeginatJJ Exp Med200420072573510.1084/jem.20040774221196315381728In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidasePopaERFranssenCFLimburgPCHuitemaMGKallenbergCGTervaertJWArthritis Rheum2002461894190410.1002/art.1038412124874CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patientsOrdonezLBernardIL'Faqihi-OliveFECohen TervaertJWDamoiseauxJSaoudiAPLOS One20094e528710.1371/journal.pone.0005287266807119381293Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitisMarinakiSKälschAIGrimmingerPBreedijkABirkRSchmittWHWeissCvan der WoudeFJYardBANephrol Dial Transplant2006211825183210.1093/ndt/gfl09716567340Epigenetic modification of the CCR6 gene is associated with stable CCR6 expression in T cellsSteinfelderSFloessSEngelbertDHaeringerBBaronURivinoLSteckelBGruetzkauAOlekSGeginatJHuehnJHamannABlood20111172839284610.1182/blood-2010-06-29302721228329CCR7 expression and memory T cell diversity in humansCampbellJJMurphyKEKunkelEJBrightlingCESolerDShenZBoisvertJGreenbergHBVierraMAGoodmanSBGenoveseMCWardlawAJButcherECWuLJ Immunol200116687788411145663Integrating conflicting chemotactic signals. The role of memory in leukocyte navigationFoxmanEFKunkelEJButcherECJ Cell Biol199914757758810.1083/jcb.147.3.577215117610545501Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgarisTerakiYMiyakeATakebayashiRShioharaTClin Exp Dermatol20042965866310.1111/j.1365-2230.2004.01638.x15550147Phenotypic and functional characterization of CCR7+ and CCR7- CD4+ memory T-cells homing to the joints in juvenile idiopathic arthritisGattornoMPrigioneIMorandiFGregorioAChiesaSFerlitoFFavreAUccelliAGambiniCMartiniAPistoiaVArthritis Res Ther20057R256267106532315743472Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissueDebesGFArnoldCNYoungAJKrautwaldSLippMHayJBButcherECNat Immunol2005688989410.1038/ni1238214491616116468Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphaticsBromleySKThomasSYLusterADNat Immunol2005689590110.1038/ni124016116469Tissue trafficking patterns of effector memory CD4+ T cells in rheumatoid arthritisZhangXNakajimaTGoronzyJJWeyandCMArthritis Rheum2005523839384910.1002/art.2148216329093